Plasma levels of both ANP and BNP are markedly elevated under the pathophysiological conditions of cardiac dysfunction, fibrosis, hypertrophy, pulmonary embolism, and congestive heart failure [66,67,96,97,98,99,100,101]. Here, NPPB is linked to cardiac hypertrophy.